HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Open Access
- 1 April 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50 (4), 716-722
- https://doi.org/10.1194/jlr.m800607-jlr200
Abstract
Enhanced oxidative stress is implicated in the development of atherosclerosis in humans and animal models. F-2-isoprostanes are formed in vivo via free radical peroxidation of arachidonic acid, and their quantification has allowed assessment of oxidative stress in vivo. F-2-isoprostanes associate with lipids, although their distribution in human plasma lipoproteins is unknown. Our aim was to determine the distribution and levels of F-2-isoprostanes in lipoproteins isolated from human plasma by ultracentrifugation and fast protein liquid chromatography (FPLC). F-2-isoprostanes were significantly higher in HDL compared with LDL or VLDL after isolation by ultracentrifugation or FPLC. Furthermore, HDL3 particles contained elevated levels of F-2-isoprostanes compared with HDL2. Platelet activating factor acetylhydrolase (PAF-AH), which hydrolyses esterified F-2-isoprostanes from phospholipids, was predominantly associated with LDL. Reduced F-2-isoprostanes in LDL may be related to higher PAF-AH activity in LDL. Paraoxonase 1 (PON-1) activity was associated with HDL2 and may be a contributing factor to the lower F-2-isoprostanes in HDL2 compared with HDL3. Further studies are required to establish the implications of these findings on HDL function.-Proudfoot, J. M., A. E. Barden, W. M. Loke, K. D. Croft, I. B. Puddey, and T. A. Maori. HDL is the major lipoprotein carrier of plasma F-2-isoprostanes. J. Lipid Res. 2009. 50: 716-722.This publication has 53 references indexed in Scilit:
- The emerging roles of PAF acetylhydrolaseJournal of Lipid Research, 2009
- Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)Cardiovascular Drugs and Therapy, 2008
- Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic ReviewMayo Clinic Proceedings, 2007
- Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery diseaseFree Radical Biology & Medicine, 2006
- Semiautomated Method for Determination of Serum Paraoxonase Activity Using Paraoxon as SubstrateClinical Chemistry, 2006
- Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F 2α -IIICirculation, 2005
- Antiinflammatory Properties of HDLCirculation Research, 2004
- Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cellsBiochemical and Biophysical Research Communications, 2004
- The Role of Copper Reduction by α-Tocopherol in Low-Density Lipoprotein OxidationFree Radical Biology & Medicine, 1997
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989